PMID- 36543706 OWN - NLM STAT- MEDLINE DCOM- 20230214 LR - 20230219 IS - 1590-3729 (Electronic) IS - 0939-4753 (Linking) VI - 33 IP - 2 DP - 2023 Feb TI - Effects of whey protein supplementation on adiposity, body weight, and glycemic parameters: A synthesis of evidence. PG - 258-274 LID - S0939-4753(22)00397-0 [pii] LID - 10.1016/j.numecd.2022.09.014 [doi] AB - AIMS: The aim of this review was to analyze the evidence of whey protein supplementation on body weight, fat mass, lean mass and glycemic parameters in subjects with overweight or type 2 diabetes mellitus (T2DM) undergoing calorie restriction or with ad libitum intake. DATA SYNTHESIS: Overweight and obesity are considered risk factors for the development of chronic noncommunicable diseases such as T2DM. Calorie restriction is a dietary therapy that reduces weight and fat mass, promotes the improvement of glycemic parameters, and decreases muscle mass. The maintenance of muscle mass during weight loss is necessary in view of its implication in preventing chronic diseases and improving functional capacity and quality of life. The effects of increased protein consumption on attenuating muscle loss and reducing body fat during calorie restriction or ad libitum intake in overweight individuals are discussed. Some studies have demonstrated the positive effects of whey protein supplementation on improving satiety and postprandial glycemic control in short term; however, it remains unclear whether long-term whey protein supplementation can positively affect glycemic parameters. CONCLUSIONS: Although whey protein is considered to have a high nutritional quality, its effects in the treatment of overweight, obese individuals and those with T2DM undergoing calorie restriction or ad libitum intake are still inconclusive. CI - Copyright (c) 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. FAU - Giglio, Bruna M AU - Giglio BM AD - Faculty of Nutrition, Federal University of Goias, Goiania, GO, Brazil. FAU - Lobo, Patricia C B AU - Lobo PCB AD - Faculty of Nutrition, Federal University of Goias, Goiania, GO, Brazil. FAU - Pimentel, Gustavo D AU - Pimentel GD AD - Faculty of Nutrition, Federal University of Goias, Goiania, GO, Brazil. Electronic address: gupimentel@yahoo.com.br. LA - eng PT - Journal Article PT - Review DEP - 20220928 PL - Netherlands TA - Nutr Metab Cardiovasc Dis JT - Nutrition, metabolism, and cardiovascular diseases : NMCD JID - 9111474 RN - 0 (Whey Proteins) SB - IM MH - Humans MH - Whey Proteins/adverse effects MH - *Overweight/diagnosis MH - Adiposity MH - *Diabetes Mellitus, Type 2/diagnosis/prevention & control MH - Quality of Life MH - Body Mass Index MH - Obesity MH - Dietary Supplements/adverse effects MH - Body Weight OTO - NOTNLM OT - Body weight maintenance OT - Calorie restriction OT - Obesity OT - Whey protein EDAT- 2022/12/22 06:00 MHDA- 2023/02/15 06:00 CRDT- 2022/12/21 21:57 PHST- 2022/02/11 00:00 [received] PHST- 2022/09/16 00:00 [revised] PHST- 2022/09/19 00:00 [accepted] PHST- 2022/12/22 06:00 [pubmed] PHST- 2023/02/15 06:00 [medline] PHST- 2022/12/21 21:57 [entrez] AID - S0939-4753(22)00397-0 [pii] AID - 10.1016/j.numecd.2022.09.014 [doi] PST - ppublish SO - Nutr Metab Cardiovasc Dis. 2023 Feb;33(2):258-274. doi: 10.1016/j.numecd.2022.09.014. Epub 2022 Sep 28.